Efficacy and safety of ophthalmic epinastine evaluated using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis

被引：0

作者：

Schiffman, RM

Abelson, MB

Crampton, HJ

Slugg, AP

Michaelson, C

Bradford, RR

Kim, B

Lue, JC

Whitcup, SM

机构：

[1] Allergan Pharmaceut Inc, Irvine, CA USA

[2] Schepens Eye Res Inst, Boston, MA USA

[3] Ophthalm Res Associates, N Andover, MA USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

107

引用

页码：U17 / U17

页数：1

共 50 条

[41] Efficacy and tolerability of ophthalmic epinastine: A randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis
Whitcup, SM
Bradford, R
Lue, J
Schiffman, RM
Abelson, MB
CLINICAL THERAPEUTICS, 2004, 26 (01) : 29 - 34
[42] COMPARATIVE STUDY OF THE OCULAR EFFICACY AND SAFETY OF DICLOFENAC SODIUM 0.1% OPHTHALMIC SOLUTION WITH THAT OF KETOROLAC TROMETHAMINE 0.5% OPHTHALMIC SOLUTION IN PATIENTS WITH ACUTE SEASONAL ALLERGIC CONJUNCTIVITIS
Dehar, Navdeep
Gupta, Anita
Singh, Gursatinder
JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1121 - 1121
[43] Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients
Lichtenstein, SJ
Rinehart, M
JOURNAL OF AAPOS, 2003, 7 (05): : 317 - 324
[44] BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% PROVIDES A RAPID AND SUSTAINED REDUCTION IN OCULAR ITCH FOR SEVERELY ALLERGIC SUBJECTS FOLLOWING EXPOSURE TO RAGWEED OR GRASS POLLENS USING THE CONJUNCTIVAL ALLERGEN CHALLENGE (CAC) MODEL OF ALLERGIC CONJUNCTIVITIS
Munoz, M.
Williams, J. I.
Gow, J. A.
Schooley, G. L.
McNamara, T. R.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A113 - A113
[45] Bepotastine Besilate Ophthalmic Solution 1.5% Produces Strong Clinical Benefit for Ocular Itching Immediately Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis
Clark, J. C.
Williams, J. I.
Gomes, P. J.
Abelson, M. B.
Gow, J. A.
McNamara, T. R.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB256 - AB256
[46] A comparison of Zaditor® (Ketotifen Fumarate 0.025% Ophthalmic Solution) versus Alocril™ (Nedocromil Sodium 2% Ophthalmic Solution) in preventing ocular itching as induced by the conjunctival allergen challenge model of acute allergic conjunctivitis
Crampton, J
Slugg, AP
Minno, G
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U19 - U19
[47] TREATMENT OF OCULAR ITCHING WITH BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% FOR SUBJECTS WITH MORE SEVERE ITCHING RESPONSE IN A CONJUNCTIVAL ALLERGEN CHALLENGE (CAC) CLINICAL MODEL OF ALLERGIC CONJUNCTIVITIS
Kennedy, K. S.
Williams, J. I.
Gow, J. A.
Abelson, M. B.
McNamara, T. R.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A129 - A129
[48] Evaluating Sustained Release Dexamethasone for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge (Ora-CAC®) Model
Bassett, Michael
Mulani, Deepa
Blizzard, Charles D.
Driscoll, Arthur
Sawhney, Amar
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[49] Rhinorrhea Reduction Using BepreveTm Ophthalmic Solution 1.5% in a Clinical Model of Allergic Conjunctivitis: An Analysis of Pooled Data From Two Phase 3 Conjunctival Allergen Challenge (CAC) Clinical Trials
Gow, J. A.
Williams, J. I.
Gomes, P. J.
Abelson, M. B.
McNamara, T. R.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
[50] Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model
Abelson, MB
Chapin, MJ
Kapik, BM
Shams, NBK
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (05) : 626 - 630

← 1 2 3 4 5 →